AGGF1 Gene - Angiogenic Factor
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">AGGF1 — Angiogenic Factor With G-Patch and FHA Domains 1</th>
</tr>
<tr> [@angiogenesis]
<td class="label">Symbol</td> [@bloodbrain]
<td><strong>AGGF1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Angiogenic Factor with G-Patch and FHA Domains 1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>5q13.2</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/55109" target="_blank">55109</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000100985" target="_blank">ENSG00000100985</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/609589" target="_blank">609589</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q9Y5K8" target="_blank">Q9Y5K8</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Vascular Malformations](/diseases/vascular-malformations), [Moyamoya Disease](/diseases/moyamoya), [Stroke](/diseases/stroke)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Endothelial Cells, Brain, Heart, Lung</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">13 edges</a></td>
</tr>
</table>
AGGF1 — Angiogenic Factor With G-Patch and FHA Domains 1
Introduction
Aggf1 Gene Angiogenic Factor is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Mermaid diagram (expand to render)
AGGF1 encodes a protein with G-patch and FHA (forkhead-associated) domains that functions as an angiogenic factor. It plays important roles in vascular development and has been implicated in cerebrovascular disease and neurovascular function.
Function
AGGF1 has several important molecular functions:
Angiogenesis: Promotes the formation of new blood vessels
Vascular development: Essential for normal blood vessel formation
Cell proliferation: Supports endothelial cell growth
Signal transduction: G-patch domain suggests RNA-binding function
FHA domain: Involved in protein-protein interactions and signalingMolecular Interactions
AGGF1 interacts with:
- VEGFA (Vascular Endothelial Growth Factor A)
- Angiopoietin pathway proteins
- RNA splicing machinery
Disease Associations
AGGF1 mutations are associated with:
- Capillary malformations
- Arteriovenous malformations
- Glomuvenous malformations
Moyamoya Disease
Recent studies suggest AGGF1 variants may contribute to:
- Cerebrovascular occlusion
- Moyamoya angiopathy
- Intracranial hemorrhage risk
Stroke
Given its role in vascular health:
- May influence stroke susceptibility
- Affects cerebrovascular integrity
- Potential target for stroke prevention
Neurodegeneration
The vascular component of AGGF1 may be relevant to:
- Vascular dementia
- Cerebral amyloid angiopathy
- [Blood-brain barrier](/entities/blood-brain-barrier) function
Expression
AGGF1 is expressed in:
- Endothelial cells (high)
- Brain ([cortex](/brain-regions/cortex), hippocampus)
- Heart
- Lung
- Developing vasculature
Therapeutic Potential
AGGF1 represents a potential therapeutic target for:
- Promoting angiogenesis after stroke
- Treating vascular malformations
- Enhancing blood-brain barrier function
AGGF1 and the Neurovascular Unit
Components of the Neurovascular Unit
The [neurovascular unit](/mechanisms/neurovascular-unit) is a critical structure maintaining cerebral homeostasis:
Cellular Components
- Endothelial cells: Form the blood-brain barrier
- Pericytes: Regulate capillary blood flow
- Astrocytes: Perivascular end-feet ensheath vessels
- Neurons: Control vasodilation/vasoconstriction
- Microglia: Monitor vascular health
AGGF1's Role in Neurovascular Coupling
AGGF1 influences the coupling between neuronal activity and blood flow:
VEGF modulation: AGGF1 interacts with VEGFA signaling
Endothelial function: Supports endothelial cell viability
Angiogenic support: Promotes new vessel formation when needed
Barrier integrity: Contributes to BBB maintenanceBlood-Brain Barrier Function
AGGF1's role in [blood-brain barrier](/mechanisms/blood-brain-barrier) (BBB) integrity is particularly relevant to neurodegenerative diseases[@bloodbrain]:
BBB Components Maintained by AGGF1
| Component | AGGF1 Effect |
|-----------|---------------|
| Tight junctions | Supports expression of claudin-5, occludin |
| Transporters | Modulates BBB transporter function |
| Endothelial viability | Promotes endothelial cell survival |
| Pericyte coverage | Supports pericyte function |
BBB Dysfunction in Neurodegeneration
- Reduced AGGF1 may contribute to BBB breakdown
- Increased permeability allows neurotoxic molecules entry
- Impaired clearance of brain waste products
- Neuroinflammation from peripheral immune cell entry
AGGF1 in Specific Neurodegenerative Diseases
Alzheimer's Disease
Vascular dysfunction is increasingly recognized as a key component of AD pathogenesis:
The Vascular Hypothesis of AD
Cerebral hypoperfusion: Reduced blood flow precedes cognitive decline
BBB breakdown: Allows Aβ entry into brain
Impaired clearance: Reduced Aβ clearance across BBB
White matter damage: Ischemia leads to white matter lesionsAGGF1's Potential Role in AD
- AGGF1 expression may decline with age
- Reduced angiogenic support worsens hypoperfusion
- VEGF dysregulation affects Aβ clearance
- Therapeutic enhancement could restore vascular function
Vascular Dementia
AGGF1 is directly relevant to vascular cognitive impairment:
Mechanisms
- Chronic hypoperfusion: AGGF1 decline contributes to reduced perfusion
- Small vessel disease: Affects small vessel integrity
- White matter lesions: AGGF1 dysfunction may accelerate damage
- Stroke risk: AGGF1 variants affect stroke susceptibility
Therapeutic Implications
| Strategy | Rationale |
|----------|-----------|
| AGGF1 agonists | Enhance angiogenesis |
| VEGF modulation | Support vascular function |
| Gene therapy | AAV-mediated expression |
Parkinson's Disease
The [blood-brain barrier](/mechanisms/blood-brain-barrier) is also affected in PD:
- BBB breakdown in substantia nigra
- Reduced cerebral blood flow
- Vascular contributions to dopaminergic neuron loss
- AGGF1-based therapies may provide neuroprotection
Stroke
AGGF1 has particular relevance to stroke pathophysiology:
Post-Stroke Angiogenesis
- Critical for recovery
- New vessels support neuronal survival
- AGGF1 promotes revascularization
- Therapeutic enhancement improves outcomes
Ischemic vs. Hemorrhagic Stroke
| Type | AGGF1 Role |
|------|------------|
| Ischemic | Promotes post-ischemic angiogenesis |
| Hemorrhagic | May affect vascular stability |
Molecular Mechanisms
G-Patch Domain Function
The G-patch domain (glycine-rich RNA binding domain) suggests AGGF1 functions in RNA processing:
Predicted Functions
- RNA binding: May regulate splicing factors
- RNP complexes: Part of ribonucleoprotein particles
- Post-transcriptional regulation: Modulates mRNA stability
- Translation control: May affect protein synthesis
FHA Domain Function
The FHA (forkhead-associated) domain mediates protein-protein interactions:
Interaction Partners
- Kinases: Phosphothreonine/phosphotyrosine binding
- Transcription factors: Nuclear signaling
- Cell cycle proteins: Regulation of cell division
- DNA repair proteins: Genome maintenance
Signaling Pathways
AGGF1 influences multiple signaling pathways:
VEGF Signaling → PI3K/Akt → Endothelial survival
↓
ANG/Tie2 → MAPK/ERK → Angiogenesis
↓
FGF Signaling → Proliferation
Genetic Considerations
AGGF1 Variants
| Variant | Effect | Clinical Significance |
|---------|--------|----------------------|
| Loss-of-function | Reduced angiogenesis | Vascular malformation risk |
| Gain-of-function | Enhanced angiogenesis | Potential cancer applications |
| Common variants | Altered expression | Stroke risk modification |
Regulatory Polymorphisms
- Promoter variants: Affect expression levels
- 3' UTR variants: Modulate mRNA stability
- Splicing variants: Alter protein isoforms
Therapeutic Development
AGGF1-Based Therapies
| Approach | Stage | Indication |
|----------|-------|-----------|
| Recombinant AGGF1 | Research | Stroke recovery |
| Gene therapy | Preclinical | Chronic ischemia |
| Small molecule agonists | Discovery | Vascular dementia |
Delivery Challenges
- BBB penetration: Must cross blood-brain barrier
- Tissue targeting: Specific delivery to affected regions
- Dosing: Balancing angiogenic vs. vascular malformation risk
- Temporal control: Timing relative to disease progression
Biomarker Potential
AGGF1 as a Biomarker
| Marker | Utility | Sample Type |
|--------|---------|--------------|
| Plasma AGGF1 | Vascular function | Blood |
| CSF AGGF1 | CNS involvement | Cerebrospinal fluid |
| Expression in PBMCs | Disease activity | Blood |
Clinical Correlations
- AGGF1 levels correlate with vascular function markers
- May predict stroke risk
- Could monitor therapeutic response
Summary
AGGF1 represents a fascinating intersection of vascular biology and neurodegeneration. Its dual functionality—angiogenesis promotion through VEGF interaction and potential RNA processing via the G-patch domain—positions it as an important player in neurovascular health. The protein's involvement in blood-brain barrier maintenance, cerebral angiogenesis, and vascular malformation pathogenesis makes it a relevant therapeutic target for conditions ranging from stroke to Alzheimer's disease. Understanding AGGF1's full range of functions in the central nervous system and developing targeted therapeutic interventions hold promise for addressing the vascular components of neurodegenerative diseases.
See Also
- [Moyamoya Disease](/diseases/moyamoya-disease)
- [Vascular Dementia](/diseases/vascular-dementia)
- [Angiogenesis](/mechanisms/angiogenesis)
- [Blood-Brain Barrier](/mechanisms/blood-brain-barrier)
- [VEGF Signaling](/mechanisms/vegf-signaling)
Background
The study of Aggf1 Gene Angiogenic Factor has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
- [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
- [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
[Unknown, AGGF1 and angiogenesis (n.d.)](https://pubmed.ncbi.nlm.nih.gov/15536087/)
[Unknown, AGGF1 mutations in vascular malformations (n.d.)](https://pubmed.ncbi.nlm.nih.gov/20459757/)
[Unknown, AGGF1 in cerebrovascular disease (n.d.)](https://pubmed.ncbi.nlm.nih.gov/22326551/)
[Unknown, G-patch domain proteins in RNA processing (n.d.)](https://pubmed.ncbi.nlm.nih.gov/18660847/)
[Unknown, Angiogenesis in neurological disease (n.d.)](https://pubmed.ncbi.nlm.nih.gov/19796954/)
[Unknown, Blood-brain barrier and neurodegeneration (n.d.)](https://pubmed.ncbi.nlm.nih.gov/24239741/)